Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Precigen Bioinformatics Germany GmbH, formerly known as Intrexon Bioinformatics Germany GmbH, is a Munich-based bioinformatics subsidiary of Precigen, Inc. The company serves as a specialized hub for genomic, transcriptomic, and epigenomic analysis, leveraging the technology and expertise of its predecessor, Genomatix Software. Its primary focus is the mapping of complex eukaryotic gene regulation to support the design of advanced gene networks for human therapeutics and animal science. The company provides proprietary software tools and services that analyze data from next-generation sequencing (NGS), ChipSeq, and microarrays to create robust biological models. These capabilities are integral to Precigen's broader mission of developing precision gene and cell therapies for immuno-oncology, autoimmune disorders, and infectious diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Intrexon Bioinformatics Germany.